Live
Home·Deals·Biotechnology·Sensei Bio acquires Faeth Therapeutics
SEO URLwww.firestrike.ai/deals/faeth-therapeutics-sensei-bio-acquisition-2026
acquisitionAnnounced · Feb 18, 2026BiotechnologySource · Unverified ReportsArticle · Factual
Faeth Therapeutics
Sensei Bio
Faeth Therapeutics · Sensei Bio

Sensei Bio acquires Faeth Therapeutics

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$200M
Target
Faeth Therapeutics
Faeth Therapeutics
Austin, Texas
Acquirer
Sensei Bio
Sensei Bio
Full Acquisition
Status
Announced

Sensei Bio agreed to acquire Faeth Therapeutics. Reported deal value: $200M. Status: Announced. Sector: Biotechnology. Target headquarters context: Austin, Texas, United States.

This page summarizes publicly available information about the transaction as of 2026-02-18. Figures and status may change as filings and press coverage update.

Shares of Sensei Biotherapeutics shot up over 20 0 % on Wednesday after the company strengthened its oncology pipeline by announcing the acquisition of Faeth Therapeutics

Deal timeline

Announced
Feb 18, 2026 · newsable.asianetnews.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Biotechnology with a reported deal value of $200M. Figures and status may change as sources update.

Sources: newsable.asianetnews.com · Primary article · FireStrike proprietary index